UK highlights life sciences’ key role in post-COVID recoveryThe UK government used the Queen’s Speech to set out its ambition to make the country a leader Share XUK highlights life sciences’ key role in post-COVID recoveryhttps://pharmaphorum.com/news/uk-highlights-life-sciences-key-role-in-post-covid-recovery/
UK ‘planning to widen AstraZeneca COVID jab restrictions’Reports are emerging that the UK may join other countries in imposing restrictions on the use of AstraZeneca’s Share XUK ‘planning to widen AstraZeneca COVID jab restrictions’https://pharmaphorum.com/news/uk-planning-to-widen-astrazeneca-covid-jab-restrictions/
New UK biotech Inspira uncloaks with deal to develop inhaled COVID therapyUK biotech Inspira Pharmaceuticals has emerged from stealth mode with a deal with Vectura to develop an inhaled Share XNew UK biotech Inspira uncloaks with deal to develop inhaled COVID therapyhttps://pharmaphorum.com/news/new-uk-biotech-inspira-uncloaks-with-deal-to-develop-inhaled-covid-therapy/
Creating a global life sciences superpower from the lessons of COVIDIt’s time to take what the UK has learnt about the “Holy Trinity” of government, academia, and industry Share XCreating a global life sciences superpower from the lessons of COVIDhttps://pharmaphorum.com/views-and-analysis/creating-a-global-life-sciences-superpower-from-the-lessons-of-covid-uk/
Apple, Google block NHS contact tracing app update on privacy groundsA scheduled update to the NHS COVID-19 app has been blocked because it allows location tracking – something Share XApple, Google block NHS contact tracing app update on privacy groundshttps://pharmaphorum.com/news/apple-google-block-nhs-contact-tracing-app-update-on-privacy-grounds/
Cancer Research UK spinout Achilles raises $175.5m in IPOUK biotech Achilles Therapeutics has completed its initial public offering (IPO) in the US, raising $175.5 million that Share XCancer Research UK spinout Achilles raises $175.5m in IPOhttps://pharmaphorum.com/news/cancer-research-uk-spinout-achilles-raises-175-5m-in-ipo/
Could Moderna shot save UK’s under-50s COVID vaccination push?People in the UK will start receiving doses of Moderna’s COVID-19 vaccine in around two weeks’ time, according Share XCould Moderna shot save UK’s under-50s COVID vaccination push?https://pharmaphorum.com/news/could-moderna-shot-save-uks-under-50s-covid-vaccination-push/
UK government launches new office to “level up” nation’s healthThe government has continued its shake-up of UK health authorities with the creation of the Office of Health Share XUK government launches new office to “level up” nation’s healthhttps://pharmaphorum.com/news/no-10-launches-new-office-to-level-up-nations-health/
NICE says no to AZ’s Lynparza for prostate cancerNHS patients in England will not be able to get access to AstraZeneca’s PARP inhibitor Lynparza if they Share XNICE says no to AZ’s Lynparza for prostate cancerhttps://pharmaphorum.com/news/nice-says-no-to-azs-lynparza-for-prostate-cancer/
